Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights
Today, 3:58 AM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

AGIO

Read More
1 minute read
  • Long Ideas
  • Markets
  • Media
  • News
  • Small Cap
  • Trading Ideas

Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More

By Priya Nigam
Today, 3:58 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.

AAL

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today

By Benzinga Insights
Today, 3:58 AM
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 16.51% on an annualized basis producing an average annual return of 22.72%. Currently, Edwards Lifesciences has a market capitalization of $55.48 billion.

EW

Read More
24 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Options
  • Trading Ideas

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
Today, 3:58 AM
  On Friday, 422 stocks made new 52-week lows.

AAT

Read More
1 minute read
  • Analyst Ratings

Where Edwards Lifesciences Stands With Analysts

By Benzinga Insights
Today, 3:58 AM
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

EW

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Buy on Edwards Lifesciences, Lowers Price Target to $115

By Benzinga Newsdesk
Today, 3:58 AM
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $134 to $115.

EW

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Canaccord Genuity Maintains Buy on Edwards Lifesciences, Lowers Price Target to $137

By Benzinga Newsdesk
Today, 3:58 AM
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $152 to $137.

EW

Read More
1 minute read
  • Earnings
  • News

Edwards Lifesciences Q1 Adj. EPS $0.60 Beats $0.57 Estimate, Sales $1.34B Beat $1.31B Estimate

By Benzinga Newsdesk
Today, 3:58 AM
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.57 by 5.26 percent. This is a 11.11 percent increase over earnings of $0.54 per share from the

EW

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Edwards Lifesciences

By Benzinga Insights
Today, 3:58 AM
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:

EW

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Truist Securities Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces Price Target of $145

By Benzinga Newsdesk
Today, 3:58 AM
Truist Securities analyst Richard Newitter initiates coverage on Edwards Lifesciences (NYSE:EW) with a Buy rating and announces Price Target of $145.

EW

Posts navigation

Previous 1 … 6 7 8 … 17 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service